PHIO PHARMACEUTICALS CORP. Diluted Shares Outstanding (Weighted Average)
PHIO PHARMACEUTICALS CORP. (PHIO) reported Diluted Shares Outstanding (Weighted Average) of 4.79 million shares for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2025-08-14
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 4.79M shares, a 839.82% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2025-03-31 was 4.31M shares, a 5.96% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2024-12-31 was 1.14M shares, a 240.13% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for the quarter ending 2024-09-30 was 990.03K shares, a 265.15% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for fiscal 2024 was 787.47K shares, a 240.15% increase from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for fiscal 2023 was 231.51K shares, a 79.63% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.14M shares, a 6.30% increase from fiscal 2021.
- PHIO PHARMACEUTICALS CORP. weighted average number of shares outstanding, diluted for fiscal 2021 was 1.07M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 4.79M shares 10-Q · filed 2025-08-14 | 4.55M shares 10-Q · filed 2025-08-14 | 3.41M shares derived: average of 3 quarters · filed 2025-08-14 | 2.81M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2025-03-31 | 4.31M shares 10-Q · filed 2025-05-15 | 2.72M shares derived: average of 2 quarters · filed 2025-05-15 | 2.14M shares derived: average of 3 quarters · filed 2025-05-15 | 1.74M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-12-31 | 1.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 1.06M shares derived: average of 2 quarters · filed 2025-03-31 | 879.15K shares derived: average of 3 quarters · filed 2025-08-14 | 787.47K shares 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | 990.03K shares 10-Q · filed 2024-11-14 | 750.11K shares derived: average of 2 quarters · filed 2025-08-14 | 670.88K shares 10-Q · filed 2024-11-14 | 1.60M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | 510.19K shares 10-Q · filed 2025-08-14 | 509.54K shares 10-Q · filed 2025-08-14 | 1.81M shares derived: average of 3 quarters · filed 2025-08-14 | 1.42M shares derived: average of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | 4.58M shares 10-Q · filed 2025-05-15 | 2.46M shares derived: average of 2 quarters · filed 2025-05-15 | 1.73M shares derived: average of 3 quarters · filed 2025-05-15 | 1.34M shares derived: average of 4 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | 334.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | 302.74K shares derived: average of 2 quarters · filed 2025-03-31 | 265.84K shares derived: average of 3 quarters · filed 2025-03-31 | 231.51K shares 10-K · filed 2025-03-31 | 2.08M shares 10-K · filed 2024-04-01 | |||
| 2023-09-30 | 271.13K shares 10-Q · filed 2024-11-14 | 2.44M shares 10-Q · filed 2023-11-09 | 231.59K shares derived: average of 2 quarters · filed 2024-11-14 | 197.23K shares 10-Q · filed 2024-11-14 | 1.78M shares 10-Q · filed 2023-11-09 | 686.11K shares derived: average of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | 192.05K shares 10-Q · filed 2024-08-14 | 1.73B shares 10-Q · filed 2023-08-10 | 159.66K shares 10-Q · filed 2024-08-14 | 1.44B shares 10-Q · filed 2023-08-10 | 824.43K shares derived: average of 3 quarters · filed 2024-08-14 | 902.97K shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 1.14M shares 10-Q · filed 2024-05-09 | 1.14M shares derived: average of 2 quarters · filed 2024-05-09 | 1.14M shares derived: average of 3 quarters · filed 2024-05-09 | 285.41M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 1.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | 1.14M shares derived: average of 2 quarters · filed 2024-04-01 | 380.17M shares derived: average of 3 quarters · filed 2024-04-01 | 1.14M shares 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | 1.14M shares 10-Q · filed 2023-11-09 | 13.66M shares 10-Q · filed 2022-11-10 | 569.68M shares derived: average of 2 quarters · filed 2023-11-09 | 1.14M shares 10-Q · filed 2023-11-09 | 13.63M shares 10-Q · filed 2022-11-10 | 276.75M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 1.14B shares 10-Q · filed 2023-08-10 | 13.66M shares 10-Q · filed 2022-08-11 | 1.13B shares 10-Q · filed 2023-08-10 | 13.61M shares 10-Q · filed 2022-08-11 | 368.62M shares derived: average of 3 quarters · filed 2023-08-10 | 279.85M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 1.13M shares 10-Q · filed 2023-05-11 | 13.56M shares 10-Q · filed 2022-05-12 | -16.19M shares derived: average of 2 quarters · filed 2023-05-11 | -6.28M shares derived: average of 3 quarters · filed 2023-05-11 | -1.33M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -33.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -9.98M shares derived: average of 2 quarters · filed 2023-03-22 | -2.14M shares derived: average of 3 quarters · filed 2023-03-22 | 1.07M shares 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | 13.53M shares 10-Q · filed 2022-11-10 | 13.53M shares derived: average of 2 quarters · filed 2022-11-10 | 12.59M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 13.53M shares 10-Q · filed 2022-08-11 | 12.12M shares 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | 10.68M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |